A Simple and Convenient Synthesis of 1,2-Benzoxazoles Via Intramolecular Mitsunobu Reaction from Salicylaldoximes and Orthohydroxyarylketoximes.
摘要:
Various substituted 1,2-benzoxazoles were prepared with good yields from salicylaldoximes and orthohydroxyphenylketoximes via intramolecular Mitsunobu reaction.
[EN] MODULATORS OF THE INTEGRATED STRESS PATHWAY<br/>[FR] MODULATEURS DE LA VOIE DE RÉPONSE INTÉGRÉE AU STRESS
申请人:CALICO LIFE SCIENCES
公开号:WO2017193063A1
公开(公告)日:2017-11-09
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
本文提供了用于调节综合应激反应(ISR)并治疗相关疾病、疾患和症状的化合物、组合物和方法。
Hepatitis C Virus Inhibitors
申请人:Bristol-Myers Squibb Company
公开号:US20130183269A1
公开(公告)日:2013-07-18
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Macrocyclic peptides are disclosed having the general formula:
wherein R
3
, R
3
′, R
4
, R
6
, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Macrocyclic peptides are disclosed having the general formula:
wherein R′, R
3
, R
3′
, R
4
, R
6
, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2 and CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, CCR9-mediated diseases, as controls in assays for the identification of CCR2 antagonists, and as controls in assays for the identification of CCR9 antagonists.